PROCUREMENT OF ANTHRAX VACCINE AND BOTULINUM TOXOID PENT

File: 123096_sep96_decls5_0001.txt
Page: 0001
Total Pages: 3

Subject: PROCUREMENT OF ANTHRAX VACCINE AND BOTULINUM TOXOID PENT        

Unit: OTSG        

Parent Organization: HSC         

Box  ID: BX003201

Folder Title: PROCUREMENT OF ANTHRAX VACCINE AND BOTULINUM TOXOID                                             

Document Number:       1001

Folder Seq  #:         36


                                  ic!rf%nr.1
                                  WLUIXL I UNCLASSIFIED

                               DEPARTMENT OF THE ARMY
                              OFFICE OF THE SURGEON GENERAL
                                  5109 LEESBURG PIKE
                                FALLS CHURCH, VA 22041-3258
              REPLY M
              ATTEN'NON OF


         DASG-HCD-D (50k)


         MEMORANDUM FOR COMMANDER, U.S. ARMY MEDICAL RESEARCH AND
                          DEVELOPMENT CO    D, ATTN: SGRD-ZA, FORT DETRICK,
                          FREDERICK, MD 21701-5012

         SUBJECT: Procurement of Anthrax Vaccine and Botulinum Toxoid,
         Pentavalent (U)


         1. @ U.S. Army Medical Research and Development Command
         (USAMRDC) should initiate immediate procurement of
         anthrax vaccine for the Biological Warfare Contingency Stockpile
         using FY90 funds already provided. Estimated cost of the
         doses of anthrax vaccine is $2.4M. The contract should inc u e an
         option to procure additional doses of vaccine.

         2. @ USAMRDC should also initiate procurement for a second batch
         of                           botulinum toxoid for the Biological
         Warfare Contingency Stockpile. Award of the contract does not have
         to occur until latter part of FY91 because production of the first
         batch of               toxoid is already scheduled as stipulated by
         a contract awarded in FY89. Estimated cost of the second batch of
                                 doses is $7.5M. Also, ensure that an
         option is provided in the contract to permit procurement of
         additional doses of pentavalent botulinum toxoid.

         3.       If the decision is made to vaccinate the total U.S. force
         in the AOR, the Biological Warfare Defense Ad Hoc Committee
         recommended that a total of
         botulinum toxoid be procured. This is in addition to the FY88
xoid procurements.

         4. (U) Point of contact for this action is MAJ Robert Eng,
         DASG-HCD-D, AUTOVON 289-8163 or (703) 756-8163.

         FOR THE SURGEON GENERAL:





                                        BRUCE T. MIKETINAC
        DECLASSIFIED                    Brigadier General, MS
        ON: 1 1 DEC 96                  Director, Health Care Operations
        BY: SEC ARMY (DAMH) UNDER SEC 3.4 EO 12958
         CLASSIFIED BY: D R, HEALTH CARE OPERATIONS
         DECIASSIFY ON: OADR

                                 UNCLASSIFIED

Document 3 f:/Week-36/BX003201/PROCUREMENT OF ANTHRAX VACCINE AND BOTULINUM TOXOID/procurement of anthrax vaccine and botulinum tox:1217960927506
Control Fields 17
File Room = sep96_declassified
File Cabinet = Week-36
Box ID = BX003201
Unit = OTSG
Parent Organization = HSC
Folder Title = PROCUREMENT OF ANTHRAX VACCINE AND BOTULINUM TOXOID
Folder Seq # = 36
Subject = PROCUREMENT OF ANTHRAX VACCINE AND BOTULINUM TOX
Document Seq # = 1001
Document Date =
Scan Date =
Queued for Declassification = 01-JAN-1980
Short Term Referral = 01-JAN-1980
Long Term Referral = 01-JAN-1980
Permanent Referral = 01-JAN-1980
Non-Health Related Document = 01-JAN-1980
Declassified = 17-DEC-1996